Abstract
It has become increasingly clear that insulin resistance plays an important role in the pathogenesis of chronic diseases of Westernized societies. Compelling evidence exists not only that insulin resistance is a risk factor for diabetes mellitus (1,2) but this metabolic characteristic is also associated with hypertension and atherosclerosis (3,4). In addition, there is evidence from the Pima Indians (5) and from high-risk offspring of two NIDDM parents (6) that insulin resistance is an inherited trait. Given that there must be one or more specific underlying mechanistic defects which are responsible for insulin resistance, and given its potential importance in the pathogenesis of chronic disease, it is incumbent upon us to continue to try to identify the cellular or molecular defects which underlie this condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.F. Saad, W.C. Knowler, D.J. Pettitt, R.G. Nelson, D.M. Mott, and P.H. Bennett, The natural history of impaired glucose tolerance in the Pima Indians, N Engl J Med 319:1500 (1988).
R.A. DeFronzo, The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM, Diabetes 37:667 (1987).
M. Laakso, H. Sarlund, and L. Mykkanen, Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance, Arteriosclerosis 10:223 (1990).
E. Ferrannini, G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua, Insulin resistance in essential hypertension, N Engl J Med 317:350 (1987).
C. Bogardus, S. Lillioja, B.L. Nyomba, F. Zurlo, B.A. Swinburn, A. Esposito-del Puente, W.C. Knowler, E. Ravussin, D.M. Mott, and P.H. Bennett, Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions, Diabetes 38:1423 (1989).
B.C. Martin, J.H. Warram, A.S. Krolewski, R.N. Bergman, J.S. Soeldner, and C.R. Kahn, Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study, Lancet 340:925 (1992).
T.P. Ciaraldi, J.M. Molina, and J.M. Olefsky, Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport, J Clim Endocrinol Metab 72:876 (1991).
A.R. Saltiel, Second messengers of insulin action, Diab Care 13:244 (1990).
O.G. Kolterman, J. Insel, M. Saekow, and J.M. Olefsky, Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects, J Clin Invest 65:1272 (1980).
J.M. Olefsky, W.T. Garvey, R.R. Henry, D. Brillon, S. Matthaei, and G.R. Freidenberg, Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes, Am J Med 85:86 (1988).
L.J. Mandarino, Regulation of skeletal muscle pyruvate dehydrogenase and glycogen synthase in man, Diab Metab Rev 5:475 (1989).
J. Eriksson, A. Franssila-Kallunki, A. Ekstrand, C. Saloranta, E. Widen, C. Schalin, and L. Groop, Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus, N Engl J Med 321:337 (1989).
S.S. Rich, Mapping genes in diabetes, Diabetes 39:1315 (1990).
J.I. Rotter, C.E. Anderson, and D.L. Rimoin, Genetics of diabetes mellitus, in: “Diabetes Mellitus: Theory and Practice,” M. Ellenberg and H. Rifkin, eds., Medical Examination Publishing Co., New York (1983).
L. Doberne, M.S. Greenfield, B. Schulz, and G.M. Reaven, Enhanced glucose utilization during prolonged glucose clamp studies, Diabetes 30:829 (1981).
R. Prager, P. Wallace, and J.M. Olefsky, In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects, J Clin Invest 78:472 (1986).
S.S. Chernick, R.J. Gardiner, and R.O. Scow, Restricted passage of insulin across capillary endothelium in perfused rat adipose tissue, Am J Physiol 253:E475 (1987).
E.A. Rasio, E. Mack, R.H. Egdahl, and M.G. Herrera, Passage of insulin and inulin across vascular membranes in the dog, Diabetes 17:668 (1968).
E.A. Rasio, C.L. Hampers, J.S. Soeldner, and G.F. Cahill, Jr., Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man, J Clin Invest 46:903 (1967).
R.S. Sherwin, K.J. Kramer, J.D. Tobin, P.A. Insel, J.E. Liljenquist, M. Berman, and R. Andres, A model of the kinetics of insulin in man, J Clin Invest 53:1481 (1974).
P.A. Insel, J.E. Liljenquist, J.D. Tobin, R.S. Sherwin, P. Watkins, R. Andres, and M. Berman, Insulin control of glucose metabolism in man, J Clin Invest 55:1057 (1975).
R.N. Bergman, Y.Z. Ider, C.R. Bowden, and C. Cobelli, Quantitative estimation of insulin sensitivity, Am J Physiol 236:E667 (1979).
R.N. Bergman, L.S. Phillips, and C. Cobelli, Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose, J Clin Invest 68:1456 (1981).
M. Ader and R.N. Bergman, Insulin sensitivity in the intact organism, in: “Bailliere’s Clinics in Endocrinology and Metabolism,” K.G.M.M. Alberti, P.D. Home, and R. Taylor, eds., Bailliere Tindall, London (1987).
R.N. Bergman, Toward physiological understanding of glucose tolerance: minimal-model approach, Diabetes 38:1512 (1989).
Y.J. Yang, I.D. Hope, M. Ader, and R.N. Bergman, Insulin transport across capillaries is rate limiting for insulin action in dogs, J Clin Invest 84:1620 (1989).
M. Gaudino, Kinetics of distribution of inulin between two body water compartments, Proc Soc Exp Biol Med 70:672 (1949).
M. Ader, R.A. Poulin, Y.J. Yang, and R.N. Bergman, Dose response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of peripheral tissues, Diabetes 41:241 (1992).
D.T. Finegood, R.N. Bergman, and M. Vranic, Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates, Diabetes 36:914 (1987).
D.T. Finegood, R. N. Bergman, and M. Vranic, Modelling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps, Diabetes 37:1025 (1988).
R.A. Poulin, G. Steil, D. Banks, H. Xiang, M. Ader, and R.N. Bergman, Transcapillary insulin transport (TCIT) is rate-limiting in insulin-sensitive tissues, FASEB J 5:A653 (1991).
M. Ader, R.A. Poulin, G.M. Steil, and R.N. Bergman, Nicotinic acid induces insulin resistance at a post-capillary transport locus as demonstrated by simultaneous measures of hindlimb lymph insulin and glucose uptake, Clin Res (1992).
M.F. Saad, S. Lillioja, B.L. Nyomba, C. Castillo, R. Ferraro, M. De Gregario, E. Ravussin, W.C. Knowler, P.H. Bennett, B.V. Howard, and C. Bogardus, Racial differences in the relation between blood pressure and insulin resistance, N Engl J Med 324:733 (1991).
R. Prager, P. Wallace, and J.M. Olefsky, Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subject, Diabetes 36:607 (1987).
D.C. Bradley and R.N. Bergman, Restoration of stable metabolic conditions during islet suppression in the dog, Am J Physiol 262:E532 (1992).
D.C. Bradley, R.A. Poulin, and R.N. Bergman, Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo, Diabetes 42:296 (1993).
I. Jensen, V. Kruse, and U.D. Larsen, Scintigraphic studies in rats: kinetics of insulin analogues covering wide range of receptor affinities, Diabetes 40:628 (1991).
T. Ishida, Z. Chap, J. Chou, R.M. Lewis, C.J. Hartley, M.L. Entman, and J.B. Field, Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs, Diabetes 33:984 (1984).
R.W. Stevenson, J.A. Parsons, and K.G.M.M. Alberti, Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs, Metabolism 30:745 (1981).
M. Ader and R.N. Bergman, Peripheral effects of insulin dominate suppression of fasting hepatic glucose production, Am J Physiol 258:E1020 (1990).
A. Giacca, S. Fisher, Z.Q. Shi, R. Gupta, H.L.A. Lickley, and M. Vranic, Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs, J Clin Invest 90:1769 (1992).
K.L. Zierler and D. Rabinowitz, Effect of very small concentrations of insulin on forearm metabolism: persistence of its action on potassium and free fatty acids without its effect on glucose, J Clin Invest 43:950 (1964).
A.D. Cherrington and M. Vranic, Hormonal control of gluconeogenesis in vivo, in: “Hormonal Regulation in Gluconeogenesis,” N. Kraus-Friedman, ed., CRC Press, Boca Raton, FL (1986).
N.K. Fukagawa, K.L. Minaker, V.R. Young, and J.W. Rowe, Insulin dose-dependent reductions in plasma amino acids in man, Am J Physiol 250:E13 (1986).
N. Nurjhan, P.J. Campbell, F.P. Kennedy, J.M. Miles, and J.E. Gerich, Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans, Diabetes 35:1326 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bergman, R.N., Bradley, D.C., Ader, M. (1993). On Insulin Action in Vivo: The Single Gateway Hypothesis. In: Östenson, C.G., Efendić, S., Vranic, M. (eds) New Concepts in the Pathogenesis of NIDDM. Advances in Experimental Medicine and Biology, vol 334. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2910-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2910-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6262-3
Online ISBN: 978-1-4615-2910-1
eBook Packages: Springer Book Archive